Monashee Investment Management’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
DCP
Monashee Investment Management's AGL Position: Q4 2021 in Review
Monashee Investment Management sold out of Agilon Health (AGL) in Q4 2021, closing a stake of 3,800 shares — an estimated $2.49M sold.
Monashee Investment Management first reported a position in AGL in Q3 2021 and held it in 1 quarter. The position peaked at $2.49M in Q3 2021. 132 funds tracked by Wall St. Rank hold AGL as of Q4 2021.
- Monashee Investment Management reported no remaining Agilon Health position as of Q4 2021 after selling out during the quarter.
- Monashee Investment Management sold 3,800 Agilon Health shares in Q4 2021, an estimated $2.49M.
- Monashee Investment Management first reported a position in Agilon Health in Q3 2021 and held it in 1 quarter.
- Monashee Investment Management's Agilon Health position peaked at $2.49M in Q3 2021.
- 132 funds tracked by Wall St. Rank held Agilon Health as of Q4 2021.
Based on Monashee Investment Management's 13F filing for Q4 2021, filed 7 Feb 2022.